What is Non-Invasive Prenatal Testing (NIPT)?
Non-invasive prenatal testing (“NIPT”) is a relatively new type of screening test that can tell more about your unborn baby than ever before.
In 1997, scientists first reported the presence of small amounts of baby’s DNA (known as cell-free DNA, or cfDNA) in the mother’s blood as early as four gestational weeks1 . The rapid development of next generation sequencing technology makes it possible to detect the risk of having chromosomal abnormalities including Down Syndrome, Patau Syndrome, Edwards Syndrome and other genetic conditions non-invasively.
The American Congress of Obstetricians and Gynecologists (ACOG) Recommends all pregnant women regardless of age to be offered screening for foetal chromosomal abnormalities.2
